Upregulated SMAD3 in Pancreatic Ductal AdenocarcinomaUpregulated SMAD3 in Pancreatic Ductal Adenocarcinoma
SMAD3 has been identified as gene related to the epithelial-mesenchymal transition. Might it serve as a biomarker of poor prognosis in pancreatic cancer? Laboratory Investigation
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Epithelial Cancer | Genetics | Health | Hematology | Laboratory Medicine | Pancreas | Pancreatic Cancer